Insider Transactions in Q3 2025 at Bio Techne Corp (TECH)
Insider Transaction List (Q3 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 25
2025
|
Roeland Nusse Director |
SELL
Open market or private sale
|
Direct |
17,040
-27.66%
|
$954,240
$56.36 P/Share
|
Aug 25
2025
|
Roeland Nusse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,040
+21.67%
|
$357,840
$21.84 P/Share
|
Aug 25
2025
|
Robert V Baumgartner Director |
SELL
Open market or private sale
|
Direct |
17,040
-27.53%
|
$954,240
$56.21 P/Share
|
Aug 25
2025
|
Robert V Baumgartner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,040
+21.59%
|
$357,840
$21.84 P/Share
|
Aug 15
2025
|
James Hippel CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,926
-1.46%
|
$102,078
$53.6 P/Share
|
Aug 15
2025
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,010
+2.95%
|
-
|
Aug 15
2025
|
William Geist PRESIDENT, PROTEIN SCIENCES |
SELL
Payment of exercise price or tax liability
|
Direct |
803
-5.05%
|
$42,559
$53.6 P/Share
|
Aug 15
2025
|
William Geist PRESIDENT, PROTEIN SCIENCES |
BUY
Exercise of conversion of derivative security
|
Direct |
2,623
+14.15%
|
-
|
Aug 15
2025
|
Matthew Mc Manus President - Diag & Spatial Bio |
SELL
Payment of exercise price or tax liability
|
Direct |
880
-15.67%
|
$46,640
$53.6 P/Share
|
Aug 15
2025
|
Matthew Mc Manus President - Diag & Spatial Bio |
BUY
Exercise of conversion of derivative security
|
Direct |
2,637
+31.96%
|
-
|
Aug 15
2025
|
Shane Bohnen SVP - General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
527
-10.73%
|
$27,931
$53.6 P/Share
|
Aug 15
2025
|
Shane Bohnen SVP - General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,718
+25.91%
|
-
|
Aug 15
2025
|
Kim Kelderman Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,305
-7.79%
|
$228,165
$53.6 P/Share
|
Aug 15
2025
|
Kim Kelderman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,543
+13.39%
|
-
|
Aug 15
2025
|
Amy E. Herr Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
101
-4.48%
|
$5,353
$53.6 P/Share
|
Aug 15
2025
|
Amy E. Herr Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
279
+11.01%
|
-
|
Aug 07
2025
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,040
+7.17%
|
$105,840
$21.84 P/Share
|
Jul 29
2025
|
James Hippel CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
147,431
-53.57%
|
$8,550,998
$58.55 P/Share
|
Jul 29
2025
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
168,620
+37.99%
|
$7,419,280
$44.33 P/Share
|
Jul 22
2025
|
Kim Kelderman Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,649
-48.3%
|
$2,313,397
$53.12 P/Share
|
Jul 22
2025
|
Kim Kelderman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,176
+34.77%
|
$2,119,744
$44.33 P/Share
|
Jul 15
2025
|
Kim Kelderman Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,933
-43.83%
|
$1,679,583
$51.42 P/Share
|
Jul 15
2025
|
Kim Kelderman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,132
+32.47%
|
$1,589,808
$44.33 P/Share
|